Section 232 Tariffs on Patented Pharmaceutical Imports Take Effect
Section 232 tariffs on certain patented pharmaceutical products and active pharmaceutical ingredients (APIs) are now in effect. US Customs and Border Protection (CBP) issued implementation guidance on July 30, 2026, and new Chapter 99 reporting requirements became effective July 31, 2026. The tariffs stem from the President's April 2, 2026, proclamation following a Section 232…
Read More »